Due to the existence of TRAIL on the outer shell, the TH-NPs actively accumulate into the tumor site through TRAIL binding to the DR4/5 on HCC cells, reducing the non-targeting biodistribution of the HCQ and OXA drugs. This evidence concerns the gene TNFSF10 and neoplasm.